Advances in Dental Pharmacotherapy: Part II

  • Sat, May 30, 2020 | 1:00 PM - Sat, May 30, 2020 | 4:30 PM

Karen Baker, RPh, MS, Pharm

Karen Baker, RPh, MS, Pharm
Rolf Christensen, DDS
Aaron Stevens, DMD

CE Credits: 3.5

The range of drug therapy options available to dental practitioners has greatly expanded over the past ten years. This expansion has opened the door to unprecedented therapeutic successes as well as disastrous drug misadventures. This course will update the dental team on recent developments in dental pharmacotherapy while providing strategies for prescribing to ensure therapeutic success. Drug therapy and alternative medicine reference sources will be listed and critiqued as to usefulness in daily practice. Clinically relevant information about effectiveness, adverse effects, patient-specific drug selection criteria, dosing, and cost will be presented for therapeutic agents commonly used in dentistry. Systemic antibiotics, anxiolytics, analgesics and mucosal disease agents will be evaluated and discussed. Special attention will be given to certain controversial areas including antibiotic premedication of joint replacement patients and office management of dental anxiety. Potentially dangerous drug and supplement interactions important in clinical dentistry will be listed and reviewed with emphasis on avoidance and patient management strategies. Extensive and very current handouts will be provided to maximize the chair-side value of this fast-paced and entertaining course.

This lecture meets Washington state opioid prescribing CE requirements.

Learning Objectives:

  • Prescribe innovative topical and systemic therapies for both inflammatory and infectious mucositis patients.
  • Choose an analgesic NSAID regimen based on relative adverse effects, drug interactions and efficacy for pain vs inflammation.
  • Enhance the analgesic effects of opioid analgesics while minimizing their adverse effects and abuse potential.

Speaker Bio

Professor Karen Baker has been on the dental faculty at the University of Iowa for 39 years and occupies a unique role in dental practice and education. She is a clinical pharmacist with a master’s degree in clinical pharmacology and therapeutics and is focused on patient-specific dental drug therapy. She has given well over 1,000 invited programs nationally and internationally and holds memberships in many dental and clinical pharmacology and therapeutics organizations. Her dental education-based pharmacy and drug therapy consultation center is the only one in the United States.

PNDC PACE
"State":"WA"